• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重症新冠疾病中,膜联蛋白-V阳性细胞外囊泡水平升高。

Annexin-V positive extracellular vesicles level is increased in severe COVID-19 disease.

作者信息

Jacob Valentine, Lambour Alexis, Swinyard Benjamin, Zerbib Yoann, Diouf Momar, Soudet Simon, Brochot Etienne, Six Isabelle, Maizel Julien, Slama Michel, Guillaume Nicolas

机构信息

Department of Human Biology Center, Amiens University Medical Center, Amiens, France.

EA HEMATIM 4666, Jules Verne University of Picardie, Amiens, France.

出版信息

Front Med (Lausanne). 2023 Jun 2;10:1186122. doi: 10.3389/fmed.2023.1186122. eCollection 2023.

DOI:10.3389/fmed.2023.1186122
PMID:37332749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10272544/
Abstract

OBJECTIVES

To evaluate extracellular vesicles levels in a cohort of SARS-CoV-2's patients hospitalized in an intensive care unit with and without COVID-19 associated thromboembolic events.

METHODS

In this study, we aim to assess endothelial and platelet membrane-derived extracellular vesicles levels in a cohort of SARS-CoV-2 patients with and without COVID-19-associated thromboembolic events who were hospitalized in an intensive care unit. Annexin-V positive extracellular vesicles levels were prospectively assessed by flow cytometry in one hundred twenty-three critically ill adults diagnosed with acute respiratory distress syndrome associated with a SARS-CoV-2 infection, ten adults diagnosed for moderate SARS-CoV-2 infection and 25 healthy volunteers.

RESULTS

On our critically ill patients, thirty-four patients (27.6%) had a thromboembolic event, Fifty-three (43%) died. Endothelial and platelet membrane-derived extracellular vesicles were drastically increased in SARS-CoV-2 patients hospitalized in the ICU compared to healthy volunteers. Moreover a slighty higher small/large ratio for platelets membrane-derived extracellular vesicles in patients was linked to thrombo-embolic events.

CONCLUSION

A comparison between total annexin-V positive extracellular vesicles levels in severe and moderate SARS-CoV-2 infection and healthy controls showed a significant increase in patients with severe infection and their sizes could be considered as biomarkers of SARS-CoV-2 associated thrombo-embolic events.

摘要

目的

评估入住重症监护病房的一组感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)患者中,伴有和不伴有2019冠状病毒病(COVID-19)相关血栓栓塞事件时的细胞外囊泡水平。

方法

在本研究中,我们旨在评估入住重症监护病房的一组伴有和不伴有COVID-19相关血栓栓塞事件的SARS-CoV-2患者中,内皮细胞和血小板膜来源的细胞外囊泡水平。通过流式细胞术对123例被诊断为与SARS-CoV-2感染相关的急性呼吸窘迫综合征的重症成年患者、10例被诊断为中度SARS-CoV-2感染的成年患者和25名健康志愿者,前瞻性地评估膜联蛋白V阳性细胞外囊泡水平。

结果

在我们的重症患者中,34例患者(27.6%)发生了血栓栓塞事件,53例(43%)死亡。与健康志愿者相比,入住重症监护病房的SARS-CoV-2患者中,内皮细胞和血小板膜来源的细胞外囊泡显著增加。此外,患者中血小板膜来源的细胞外囊泡的小/大比率略高与血栓栓塞事件有关。

结论

对重症和中度SARS-CoV-2感染患者及健康对照者的总膜联蛋白V阳性细胞外囊泡水平进行比较,结果显示重症感染患者的该水平显著升高,其大小可被视为SARS-CoV-2相关血栓栓塞事件的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7966/10272544/b52f2d06b1c5/fmed-10-1186122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7966/10272544/d1c872c79494/fmed-10-1186122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7966/10272544/e62326727fbf/fmed-10-1186122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7966/10272544/b52f2d06b1c5/fmed-10-1186122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7966/10272544/d1c872c79494/fmed-10-1186122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7966/10272544/e62326727fbf/fmed-10-1186122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7966/10272544/b52f2d06b1c5/fmed-10-1186122-g003.jpg

相似文献

1
Annexin-V positive extracellular vesicles level is increased in severe COVID-19 disease.在重症新冠疾病中,膜联蛋白-V阳性细胞外囊泡水平升高。
Front Med (Lausanne). 2023 Jun 2;10:1186122. doi: 10.3389/fmed.2023.1186122. eCollection 2023.
2
Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study.重症监护病房与非重症监护病房的新型冠状病毒 2 型(SARS-CoV-2)感染重症患者的血栓栓塞发生率相似:一项回顾性队列研究
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211053315. doi: 10.1177/10760296211053315.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection.循环血小板衍生细胞外囊泡是新冠病毒感染的一个标志。
Cells. 2021 Jan 7;10(1):85. doi: 10.3390/cells10010085.
5
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
6
Worse Disease Prognosis Is Associated to an Increase of Platelet-Derived Extracellular Vesicles in Hospitalized SARS-CoV-2 Patients.住院的 SARS-CoV-2 患者中血小板衍生的细胞外囊泡增加与预后较差相关。
Dis Markers. 2022 Jul 7;2022:8074655. doi: 10.1155/2022/8074655. eCollection 2022.
7
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
8
Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19.血小板活化和部分脱敏与重症 COVID-19 患者的病毒异噬作用有关。
Blood Adv. 2022 Jul 12;6(13):3884-3898. doi: 10.1182/bloodadvances.2022007143.
9
Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.血小板可与新冠病毒RNA结合,并在新冠肺炎中发生过度活化。
Circ Res. 2020 Sep 17;127(11):1404-18. doi: 10.1161/CIRCRESAHA.120.317703.
10
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.评估人抗 SARS-CoV-2 恢复期血浆在 COVID-19 重症成人中的疗效和安全性:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y.

引用本文的文献

1
Quantification of Urine and Plasma Levels of Extracellular Vesicles in a Cohort of Kidney Transplant Recipients and Chronic Kidney Disease Patients.肾移植受者和慢性肾病患者队列中细胞外囊泡的尿液和血浆水平定量分析。
Int J Mol Sci. 2025 Apr 11;26(8):3635. doi: 10.3390/ijms26083635.
2
Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet-Leukocyte Interaction in Severe COVID-19.组织因子和血小板/白细胞标志物在外泌体中的表达反映了严重 COVID-19 中的血小板-白细胞相互作用。
Int J Mol Sci. 2023 Nov 28;24(23):16886. doi: 10.3390/ijms242316886.

本文引用的文献

1
Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.外周血单核细胞组织因子(F3 基因)转录水平和循环细胞外囊泡在严重的 2019 年冠状病毒病(COVID-19)中升高。
J Thromb Haemost. 2023 Mar;21(3):629-638. doi: 10.1016/j.jtha.2022.11.033. Epub 2022 Dec 22.
2
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles.血小板衍生的细胞外囊泡的病理生理学作用。
Semin Thromb Hemost. 2023 Apr;49(3):279-283. doi: 10.1055/s-0042-1756705. Epub 2022 Sep 29.
3
The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19.
内皮细胞与 COVID-19:日益清晰的关联 简要标题:COVID-19 中的血管内皮病。
Int J Mol Sci. 2022 May 31;23(11):6196. doi: 10.3390/ijms23116196.
4
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells.SARS-CoV-2 通过激活血小板表明受感染细胞释放了具有活性的组织因子。
Blood Adv. 2022 Jun 28;6(12):3593-3605. doi: 10.1182/bloodadvances.2022007444.
5
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19.新型冠状病毒肺炎住院患者细胞外囊泡血浆浓度的纵向趋势
Front Cell Dev Biol. 2022 Jan 17;9:770463. doi: 10.3389/fcell.2021.770463. eCollection 2021.
6
Extracellular vesicles and exosome: insight from physiological regulatory perspectives.细胞外囊泡和外泌体:来自生理调节视角的见解。
J Physiol Biochem. 2022 Aug;78(3):573-580. doi: 10.1007/s13105-022-00877-6. Epub 2022 Feb 1.
7
Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent manner.气管插管的 COVID-19 患者的血浆微颗粒以依赖磷脂酰丝氨酸的方式引起内皮细胞死亡、中性粒细胞黏附和 NETosis。
Br J Haematol. 2022 Mar;196(5):1159-1169. doi: 10.1111/bjh.18019. Epub 2022 Jan 6.
8
SARS-CoV-2 Initiates Programmed Cell Death in Platelets.新型冠状病毒在血小板中引发程序性细胞死亡。
Circ Res. 2021 Sep 3;129(6):631-646. doi: 10.1161/CIRCRESAHA.121.319117. Epub 2021 Jul 23.
9
Extracellular vesicles in endothelial cells: from mediators of cell-to-cell communication to cargo delivery tools.内皮细胞中的细胞外囊泡:从细胞间通讯介质到货物递送工具
Free Radic Biol Med. 2021 Aug 20;172:508-520. doi: 10.1016/j.freeradbiomed.2021.06.030. Epub 2021 Jun 29.
10
Comparison and Investigation of Exosomes Derived from Platelet-Rich Plasma Activated by Different Agonists.比较和研究不同激动剂激活的富血小板血浆衍生的外泌体。
Cell Transplant. 2021 Jan-Dec;30:9636897211017833. doi: 10.1177/09636897211017833.